Clinical Trials Directory

Trials / Completed

CompletedNCT00248235

Resistance Exercise Training for the Shoulder and Neck Following Surgery for Head and Neck Cancer

Randomized Controlled Trial of Progressive Resistance Exercise Training for Spinal Accessory Neurapraxia/ Neurectomy in Head and Neck Cancer Survivors

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
64 (actual)
Sponsor
University of Alberta · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the effect of a progressive therapeutic exercise program on specific physical and functional deficits in the neck and shoulder region occurring as a result of head and neck cancer treatment.

Detailed description

We will be conducting a randomized controlled trial to evaluate the effects of progressive resistance exercise training (PRET) on shoulder and neck dysfunction due to spinal accessory neurapraxia/ neurectomy in patients with head and neck cancer. Sixty-four head and neck cancer survivors will be randomly assigned to PRET or standard care. Participants assigned to the PRET group will exercise 3 times per week for 12 weeks. The goal of the exercise program will be to enhance scapular stability, and improve mobility and strength of the upper extremity. The resistance exercise program will be progressive in terms of the number of sets and repetitions performed, as well as amount lifted, depending on baseline strength levels and overall performance status. The primary outcomes for the study include pain and dysfunction, active and passive range of motion measures, strength and endurance testing, and quality of life. Nerve conduction testing and electromyography will be performed to assess/ monitor the status of the spinal accessory nerve and trapezius muscle function respectively.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExercise

Timeline

Start date
2005-09-01
Primary completion
2008-05-01
Completion
2009-01-01
First posted
2005-11-03
Last updated
2024-11-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00248235. Inclusion in this directory is not an endorsement.